NYMXFNYMOX PHARMACEUTICAL CORPvs its industry peers
A metric-by-metric comparison of NYMOX PHARMACEUTICAL CORP against SIC 2835 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NYMXFEsta | — | — | — | — | — | 49.2%#3 | — | — | — | — | -49.6%#6 | — |
| MYGN | $578M#2 | — | 1.9x#5 | 0.7x#1 | -1.6%#7 | -188.2%#13 | -47.0%#4 | -120.4%#8 | -76.1%#3 | — | -26.1%#4 | — |
| TKNO | $394M#3 | — | 6.3x#8 | 9.7x#6 | 7.4%#4 | 35.5%#4 | -41.9%#3 | -27.6%#2 | -25.2%#1 | 5#1 | 44.4%#2 | — |
| ICCC | $96M#5 | — | — | — | — | — | — | — | — | — | 69.5%#1 | — |
| IMDX | $90M#6 | — | — | 22.1x#8 | 115.6%#1 | 17.2%#8 | -1260.8%#9 | — | — | — | -55.2%#7 | — |
| BMRA | $8M#7 | — | 2.2x#6 | 1.8x#3 | -16.2%#9 | 24.1%#5 | -119.5%#6 | -103.5%#6 | — | — | -36.4%#5 | — |
| CDIO | $5M#8 | — | 0.6x#4 | 321.4x#11 | -57.5%#10 | 22.5%#6 | -43737.5%#10 | -87.5%#4 | — | — | -63.4%#8 | — |
| QCLS | $3M#9 | 0.0x#1 | 0.2x#3 | 2.2x#4 | -5.3%#8 | 50.2%#2 | -624.4%#7 | -72.3%#3 | -61.2%#2 | — | -87.4%#11 | — |
| VNRX | $3M#10 | — | — | 1.5x#2 | 40.0%#2 | 13.4%#9 | -1258.5%#8 | — | — | — | -97.8%#13 | — |
| CDIOW | $40249#12 | — | 0.0x#1 | 2.7x#5 | -57.5%#10 | 22.5%#6 | -43737.5%#10 | -87.5%#4 | — | — | -0.7%#3 | — |
| AWHL | — | — | — | — | 0.4%#6 | 2.4%#11 | -85.9%#5 | — | — | 3#2 | — | — |
| NNNN | $159M#4 | 24.8x#2 | 5.3x#7 | 18.4x#7 | 5.6%#5 | 169.9%#1 | 66.7%#1 | 21.2%#1 | — | — | -70.4%#9 | — |
| TRIB | $2.8B#1 | — | — | 45.6x#9 | 8.3%#3 | -32.4%#12 | -34.4%#2 | — | — | — | -75.0%#10 | 0.2%#1 |
| VRAX | $677685#11 | — | 0.1x#2 | 107.0x#10 | -96.0%#12 | 10.0%#10 | -97344.8%#12 | -106.4%#7 | — | — | -91.7%#12 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2835). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice